NVP-BGT226(BGT 226) is a novel class I PI3K/mTOR inhibitor for PI3K// with IC50 of 4 nM/63 nM/38 nM.
For research use only. We do not sell to patients.
| Name | NVP-BGT226 |
|---|---|
| Molecular Formula | C32H29F3N6O6 |
| Molecular Weight | 650.6 |
| Smile | Cn1c2cnc3ccc(cc3c2n(c1=O)c4ccc(c(c4)C(F)(F)F)N5CCNCC5)c6ccc(nc6)OC.C(=C\C(=O)O)\C(=O)O |
| InChiKey | YUXMAKUNSXIEKN-BTJKTKAUSA-N |
| InChi | InChI=1S/C28H25F3N6O2.C4H4O4/c1-35-24-16-33-22-6-3-17(18-4-8-25(39-2)34-15-18)13-20(22)26(24)37(27(35)38)19-5-7-23(21(14-19)28(29,30)31)36-11-9-32-10-12-36;5-3(6)1-2-4(7)8/h3-8,13-16,32H,9-12H2,1-2H3;1-2H,(H,5,6)(H,7,8)/b;2-1- |
| CAS Number | 1245537-68-1 |
| MDL | MFCD22124895 |
| Related CAS |
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Purity | 98% |
|---|---|
| Solubility | DMSO ��125mg/mL Water <1.2mg/mL Ethanol <1.2mg/mL |
| Handling | |
| HS Code |
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |